As of October 10，China Pharmaceutical Biological Products Verification Institute has accepted 175 batches of 28.51 million people H1N1 influenza vaccine approval applications，A total of 108 batches of 17.655 million people were issued.。This is a reporter learned from the National Food and Drug Administration's press conference。 
      The relevant person in charge of the China Inspection Office said at the press conference，The institute will allocate resources，Ensure that the batch of H1N1 influenza vaccine and seasonal influenza vaccine is completed on the time limit。For 8 companies that have obtained the My stake betting appStake Sports Bettingapproval of the medicine，Because the production process is different，The China Inspection Institute will conduct quality comparison research on the vaccine of different manufacturers，After forming a research report, report to the State Food and Drug Administration。In addition，H1N1 influenza vaccine cold chain preservation is very important，The China Inspection Institute will cooperate with the National Food and Drug Administration's Inspection Bureau to carry out market sampling，Organize the inspection and testing work，Make sure the vaccine safety。 
      So far，Eight companies that have approved by the State Food and Drug Administration to produce A H1N1 influenza vaccine include: Beijing Kexing Biological Products Co.stake betting app, Ltd.、Hualan Biostarity stake online sports bettingCo., Ltd.、Changchun Changsheng Biotechnology Co., Ltd.、Beijing Tiantan Biological Products Co., Ltd.、Changchun Biological Products Research Institute、Shanghai Biological Products Research Institute、Jiangsu Yanshen Biotechnology Co., Ltd.、Zhejiang Tianyuan Biopharmaceutical Co., Ltd.。